Developer docs
API playgroundTry for free, no card

Search company profiles

VitroLabs

Full company profile

uuid00043jw

Namestring
VitroLabs
Legal namestring
VitroLabs Inc.
Company typeenum
Private
Founded yearint
2016
Descriptiontext

VitroLabs was a California-based biotech company (founded 2016, headquartered in Milpitas) that developed a platform for producing real leather via cell-cultivation and tissue engineering rather than animal husbandry and conventional tanning. The company's core product was a tissue-engineering platform that grows leather cells in controlled laboratory environments to produce animal-free leather materials with properties comparable to conventional leather, eliminating factory farming and the hazardous chemicals associated with traditional tanning. The technology was protected by a portfolio of 35 patents covering cell-cultivation processes and tissue engineering methods for leather production.

Short descriptiontext

VitroLabs was a Milpitas, California-based biotech that developed a cell-cultivation and tissue-engineering platform to produce animal-free, sustainable leather for luxury fashion brands, and was acquired by Faircraft in May 2025.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Jose, United States
HQ citystring
San Jose
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cultivated leather production, cell-based leather materials, tissue engineered leather, sustainable leather alternatives, biotech leather manufacturing
Industry2 codes
PRIMARYCRAAAMAG
Leather, Suede & Alternatives (PU/Bio-based)
Consumer Products & Retail/Apparel, Footwear & Accessories/Textiles, Fabrics & Trims (Inputs & Sourcing)
SECONDARYIMAOAHAH
Vegan/Alternative Material Goods Manufacturing (PU/Plant-based/Mycelium)
NAICS code2 codes
  • Leather and Allied Product Manufacturing316
  • Other Leather and Allied Product Manufacturing316990
SIC code1 code
  • Leather & Leather Products3100
Product category
Cultivated Leather Materials
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Cultivated leather materials
TypeOne Time License
Description

Pre-commercial stage; company was building and scaling pilot production of cultivated leather for sale to luxury fashion brands. Revenue model based on selling cultivated leather materials to fashion industry customers.

prnewswire.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Pricing details1 tier
1Cultivated leather materials for luxury fashion
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Market average selling price: USD 72,500 per ton; Gross margins averaging 30%

openpr.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

VitroLabs developed a tissue engineering platform that produces real leather materials through cell-cultivation processes, creating animal-free leather without traditional animal farming or tanning methods. The platform grows leather cells in controlled laboratory environments, producing sustainable, premium-grade cultivated leather with properties identical to conventional leather for use in luxury fashion products such as bags, footwear, and accessories.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 30% gross margins indicating early signs of cost normalization in cultivated leather market
Product and service1 record
1Cell-Cultivated Leather Platform
CategoryCultivated Leather
Description

Tissue engineering platform that produces environmentally sustainable, animal-free leather through cell-culturing processes, for sale to luxury fashion manufacturers producing bags, footwear, and accessories.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-01
Description

Faircraft, a French biotech startup specializing in in-vitro leather production, acquired the assets of VitroLabs including 35 patents. The acquisition aimed to strengthen Faircraft's technological portfolio, expand market presence, and accelerate industrialization with a target production unit by 2027.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

French biotech startup that acquired VitroLabs's assets in 2025; produces cultivated leather from animal cells using tissue engineering and plans a production unit by 2027 — the closest direct peer in technology, product, and target customer.

2Modern Meadow
TypeDirect peer
Description

US-based pioneer of biofabricated leather and materials using cell biology and protein engineering; targeted fashion and automotive with the same animal-free premium-leather proposition that VitroLabs pursued.

TypeDirect peer
Description

Creator of Mylo (mycelium-based 'leather') with established luxury partnerships (Stella McCartney, Adidas, Hermès via mycoworks era), competing for the same sustainable-luxury leather off-take wallet.

TypeEmerging player
Description

Producer of Piñatex, a pineapple-leaf-fiber leather alternative serving fashion brands with a plant-based sustainability narrative that directly competes with cultivated leather for the eco-positioning slot in luxury collections.

TypeEmerging player
Description

Mycelium-materials company with divisions (Forager, MyForest Foods) producing mushroom-based 'leather' and packaging; competing alternative-leather material science play for fashion and consumer goods.

TypeEmerging player
Description

Animal-free protein producer for beauty and fashion applications (collagen/elastin via fermentation); adjacent technology platform competing for luxury fashion's sustainable ingredient budget.

TypeOthers
Description

Cultivated-meat pioneer sharing cellular-agriculture infrastructure, bioprocess know-how, and specialized investors (e.g., Agronomics) with VitroLabs; the closest adjacency for underlying biology and production know-how, though end markets differ.

TypeOthers
Description

Fermentation/fungi-based ingredients company applying similar biological-process thinking to food; represents the broader cellular-and-fungal-biotech capability set underpinning cultivated leather production.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

VitroLabs

Cultivated Leather Materialsvitrolabsinc.com

VitroLabs was a Milpitas, California-based biotech that developed a cell-cultivation and tissue-engineering platform to produce animal-free, sustainable leather for luxury fashion brands, and was acquired by Faircraft in May 2025.

What VitroLabs does

VitroLabs was a California-based biotech company (founded 2016, headquartered in Milpitas) that developed a platform for producing real leather via cell-cultivation and tissue engineering rather than animal husbandry and conventional tanning. The company's core product was a tissue-engineering platform that grows leather cells in controlled laboratory environments to produce animal-free leather materials with properties comparable to conventional leather, eliminating factory farming and the hazardous chemicals associated with traditional tanning. The technology was protected by a portfolio of 35 patents covering cell-cultivation processes and tissue engineering methods for leather production.

VitroLabs firmographics

Firmographics
Name
VitroLabs
Legal name
VitroLabs Inc.
Website
https://vitrolabsinc.com
Company type
Private
Founded year
2016
Operating status
Acquired
Headcount range
1–10 employees
Short description
VitroLabs was a Milpitas, California-based biotech that developed a cell-cultivation and tissue-engineering platform to produce animal-free, sustainable leather for luxury fashion brands, and was acquired by Faircraft in May 2025.
Ownership category
akta.pro rank

VitroLabs industry classification

Industry
Product category
Cultivated Leather Materials
NAICS
Leather and Allied Product Manufacturing (316), Other Leather and Allied Product Manufacturing (316990)
SIC
Leather & Leather Products (3100)
akta.pro industry
PRIMARYCRAAAMAG
Leather, Suede & Alternatives (PU/Bio-based)
Consumer Products & Retail/Apparel, Footwear & Accessories/Textiles, Fabrics & Trims (Inputs & Sourcing)
SECONDARYIMAOAHAH
Vegan/Alternative Material Goods Manufacturing (PU/Plant-based/Mycelium)

Keywords

  • Cultivated leather production
  • Cell-based leather materials
  • Tissue engineered leather
  • Sustainable leather alternatives
  • Biotech leather manufacturing

Where VitroLabs is headquartered

Location

Headquarters

HQ city
San Jose
HQ country
United States
HQ region
North America

Offices1 record

Markets served

VitroLabs business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. Cultivated leather materials: Pre-commercial stage; company was building and scaling pilot production of cultivated leather for sale to luxury fashion brands. Revenue model based on selling cultivated leather materials to fashion industry customers.

Pricing tiers

ModelBillingPrice
Unit PricingMulti-year contractCultivated leather materials for luxury fashion

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

VitroLabs product offering

Product offering

Core offering

VitroLabs developed a tissue engineering platform that produces real leather materials through cell-cultivation processes, creating animal-free leather without traditional animal farming or tanning methods. The platform grows leather cells in controlled laboratory environments, producing sustainable, premium-grade cultivated leather with properties identical to conventional leather for use in luxury fashion products such as bags, footwear, and accessories.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cell-Cultivated Leather Platform Tissue engineering platform that produces environmentally sustainable, animal-free leather through cell-culturing processes, for sale to luxury fashion manufacturers producing bags, footwear, and accessories.

Quantifiable outcome

  • 30% gross margins indicating early signs of cost normalization in cultivated leather market

Companies that use VitroLabs

Customer profile

Segments1 record

Ideal customer profiles1 record

VitroLabs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

VitroLabs partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • FaircraftcoreStrategic or Co-development Partner · 1 May 2025Faircraft, a French biotech startup specializing in in-vitro leather production, acquired the assets of VitroLabs including 35 patents. The acquisition aimed to strengthen Faircraft's technological portfolio, expand market presence, and accelerate industrialization with a target production unit by 2027.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

VitroLabs competitors and assessment

Company assessment

Direct peers

  • Faircraft: French biotech startup that acquired VitroLabs's assets in 2025; produces cultivated leather from animal cells using tissue engineering and plans a production unit by 2027 — the closest direct peer in technology, product, and target customer.
  • Modern Meadow: US-based pioneer of biofabricated leather and materials using cell biology and protein engineering; targeted fashion and automotive with the same animal-free premium-leather proposition that VitroLabs pursued.
  • Bolt Threads: Creator of Mylo (mycelium-based 'leather') with established luxury partnerships (Stella McCartney, Adidas, Hermès via mycoworks era), competing for the same sustainable-luxury leather off-take wallet.

Emerging players

  • Ananas Anam: Producer of Piñatex, a pineapple-leaf-fiber leather alternative serving fashion brands with a plant-based sustainability narrative that directly competes with cultivated leather for the eco-positioning slot in luxury collections.
  • Ecovative Design: Mycelium-materials company with divisions (Forager, MyForest Foods) producing mushroom-based 'leather' and packaging; competing alternative-leather material science play for fashion and consumer goods.
  • Geltor: Animal-free protein producer for beauty and fashion applications (collagen/elastin via fermentation); adjacent technology platform competing for luxury fashion's sustainable ingredient budget.

Others

  • Upside Foods: Cultivated-meat pioneer sharing cellular-agriculture infrastructure, bioprocess know-how, and specialized investors (e.g., Agronomics) with VitroLabs; the closest adjacency for underlying biology and production know-how, though end markets differ.
  • MycoTechnology: Fermentation/fungi-based ingredients company applying similar biological-process thinking to food; represents the broader cellular-and-fungal-biotech capability set underpinning cultivated leather production.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights6 records

Customer concentration

VitroLabs social profiles

Digital presence

VitroLabs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

VitroLabs leadership team

Management profile

Number of profiles

Profiles5 records

VitroLabs funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

VitroLabs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VitroLabs

What does VitroLabs do?

VitroLabs developed a tissue engineering platform that produces real leather materials through cell-cultivation processes, creating animal-free leather without traditional animal farming or tanning methods. The platform grows leather cells in controlled laboratory environments, producing sustainable, premium-grade cultivated leather with properties identical to conventional leather for use in luxury fashion products such as bags, footwear, and accessories.

Is VitroLabs a public or private company?

VitroLabs is a private company. It is classified as corporate owned and is currently acquired.

When was VitroLabs founded?

VitroLabs was founded in 2016. It employs 1 to 10 people.

Where is VitroLabs based?

VitroLabs is headquartered in San Jose, United States, in the North America region.

How does VitroLabs make money?

One revenue line is on record: cultivated leather materials.

Who are VitroLabs's main competitors?

Direct peers on record are Faircraft, Modern Meadow and Bolt Threads. Emerging players are Ananas Anam, Ecovative Design and Geltor. Others are Upside Foods and MycoTechnology.

Does VitroLabs have an API?

No public API is recorded for VitroLabs.

What industry is VitroLabs in?

VitroLabs's product category is Cultivated Leather Materials. Its primary akta.pro industry code is CRAAAMAG, Leather, Suede & Alternatives (PU/Bio-based), with a secondary code of IMAOAHAH, Vegan/Alternative Material Goods Manufacturing (PU/Plant-based/Mycelium). Its NAICS code is 316 and its SIC code is 3100.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PolesocietesFaircraft acquiert VitroLabs et renforce son leadershipFaircraft acquired VitroLabs' assets, integrating its 35 patents and San Francisco operations. The deal aims to accelerate industrialization, with a first production unit planned by 2027. VitroLabs' team will join Faircraft, and its infrastructure may support US expansion.Tech.euFaircraft acquires VitroLabs assets in effort to dominate lab-grown leather marketFaircraft acquired key assets from VitroLabs, a California startup developing lab-grown leather, to accelerate industrialization. The deal includes 30 international patents and positions Faircraft to open its first full-scale production plant within two years. The company aims to make in vitro leather a prestige material for luxury fashion houses.The GuardianPetri-dish leather and silk spun from sugar: could future fashion be grown in a lab?Start-ups and scientists are developing lab-grown alternatives to traditional fashion materials including silk, leather, and diamonds as part of efforts to reduce fashion's environmental footprint. Bolt Threads' Microsilk received a $700m valuation but currently has no products on market due to scaling difficulties with precision fermentation, while VitroLabs raised $46m in series-A funding for cultivated leather from investors including luxury conglomerate Kering but also has no commercial products. Lab-grown diamonds are already commercially available, though experts question whether sustainability claims from producers are overstated, citing concerns about energy usage and industrial feedstock sourcing.WebrazziOscar ödüllü oyuncu Leonardo Di Caprio'nun teknoloji yatırımları karnesinde öne çıkan detaylarLeonardo DiCaprio has invested in 26 technology and sustainability-focused startups since 2011, with notable recent investments in lab-grown leather producer VitroLabs and cellular agriculture company Wildtype. His portfolio includes significant stakes in entities such as Beyond Meat, Aspiration, and Polestar, reflecting a strategic focus on environmental impact and sustainable innovation.SecSEC FORM DVitrolabs Inc filed a Form D with the Securities and Exchange Commission to report an exempt offering of securities under Rule 506(b). The filing discloses that the total offering amount was $47,400,572 USD, which included approximately $13.1 million in converted indebtedness and accrued interest, sold to 60 investors. This regulatory submission serves as a formal notice of the completed or ongoing private placement.The GuardianShoes made from grapes and mushroom handbags: the rise of animal-free leatherLerins, a new sustainable trainer brand founded by Dune's Daniel Rubin, launched this week featuring shoes made from grape leather derived from wine-making waste, priced at £130. Several major fashion brands including Stella McCartney, Allbirds, Hermès, and Reformation are also adopting plant-based leather alternatives, while Leonardo DiCaprio and luxury group Kering invested in the lab-grown leather startup VitroLabs. Industry data shows $980m was raised last year for fabrics that replace animal-based materials, though analysts note durability concerns and the common use of plastic coatings in these alternatives present ongoing sustainability challenges.FinSMEsVitroLabs Raises $46M in Series A FundingVitroLabs, a biotech company based in Milpitas, California, raised $46 million in Series A funding led by Agronomics with participation from investors including Kering and Khosla Ventures. The company plans to utilize the capital to accelerate commercialization efforts and expand its scientific, manufacturing, and business development teams.Tech Funding NewsThis startup raises $46M to make lab-grown and cell-cultivated leather — TFNKering SA, the parent company of luxury brands Gucci and Saint Laurent, has invested $46 million in VitroLabs Inc., a California-based startup developing cell-cultivated leather. The Series A funding will support pilot manufacturing beginning this spring, expand scientific and manufacturing teams, and accelerate commercialization of the alternative leather material. VitroLabs claims to be the first alternative materials startup to receive investment from a major luxury conglomerate, with the broader industry raising an estimated $980 million last year according to the nonprofit Material Innovation Initiative.PR NewswireVitroLabs lève 46 millions de dollars pour développer le premier pilote de production de cuir par culture cellulaire au mondeVitroLabs Inc, a California-based biotech startup, has closed a $46 million Series A funding round led by Agronomics to build the world's first cultivated leather production pilot unit, with participation from Kering, Khosla Ventures, BESTSELLER's Invest FWD, New Agrarian, and Regeneration.VC. The company, founded in 2016 and based in Milpitas, has moved into a 4,000 m2 facility and is transitioning from research to commercialization, with Kering providing additional support on product quality testing, tanning, and finishing. The funding will accelerate scaling efforts toward industrialization of cultivated leather that replicates traditional leather properties while reducing environmental and ethical impacts.